Equities

GSK plc

GSK:LSE

GSK plc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2,198.00
  • Today's Change18.00 / 0.83%
  • Shares traded8.48m
  • 1 Year change48.56%
  • Beta0.7079
Data delayed at least 20 minutes, as of Feb 06 2026 14:54 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments3,7144,9927,877
Total Receivables, Net6,9357,4037,115
Total Inventory5,6695,4985,146
Prepaid expenses390355343
Other current assets, total289396288
Total current assets16,99718,64420,769
Property, plant & equipment, net10,0739,9579,620
Goodwill, net6,9826,8117,046
Intangibles, net15,51514,76814,318
Long term investments1,1961,1921,541
Note receivable - long term1,044950965
Other long term assets1.00--0
Total assets59,46359,00560,146
LIABILITIES
Accounts payable3,4623,7173,866
Accrued expenses10,36710,71110,587
Notes payable/short-term debt7621,0061,639
Current portion long-term debt/capital leases1,5871,8072,313
Other current liabilities, total5,5193,8274,405
Total current liabilities21,69721,06822,810
Total long term debt14,63715,20517,035
Total debt16,98618,01820,987
Deferred income tax382311289
Minority interest(585)(552)(502)
Other liabilities, total9,6619,6269,916
Total liabilities45,79245,65849,548
SHAREHOLDERS EQUITY
Common stock1,3481,3481,347
Additional paid-in capital3,4733,4513,440
Retained earnings (accumulated deficit)9,9259,3686,492
Treasury stock - common------
Unrealized gain (loss)(659)(510)(308)
Other equity, total(19)(22)(20)
Total equity13,67113,34710,598
Total liabilities & shareholders' equity59,46359,00560,146
Total common shares outstanding4,1454,0564,034
Treasury shares - common primary issue169256277
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.